Naproxen Sodium Tablet, Film Coated
Product Images NDC 65862-515

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 65862-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Naproxen Fig1)

Label for Naproxen Sodium Tablets USP, 275 mg, film-coated tablet dosage form. The label indicates a 100-tablet package distributed by Aurobindo Pharma USA, Inc., with storage instructions at 20° to 25°C and a tamper-evident container warning. The label includes the NDC 65862-515-01 and notes the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (550 mg (100 Tablet Bottle))

Label for Naproxen Sodium Tablets USP 550 mg film-coated tablets by Aurobindo Pharma Limited. The label shows the NDC number 65862-516-01 and states it is for prescription use. It includes storage instructions, dispensing guidance, and tamper-evident container warning. Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Naproxen Str)

Chemical structure of naproxen sodium, showing the molecular formula C14H13NaO3 and the sodium carboxylate functional group (R=COONa) attached to the naphthalene ring system with a methoxy substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.